GENE ONLINE|News &
Opinion
Blog

COVID-19 Treatment
EMA Begins Reviewing Cancer Medicine for COVID-19 Without Manufacturer’s Application
2022-07-28
Monoclonal Antibody Discovered to Potentially Act Against All Coronaviruses
2022-07-25
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
Genetics May Be a Factor in Varying COVID-19 Severity
2022-05-20
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20
Pfizer to Address COVID-19 Reinfection After Paxlovid Treatment
2022-05-19
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
Can Vaccination Provide Protection Against Highly Infectious BA.2 Omicron Variant?
2022-03-23
Shionogi’s COVID-19 Oral Drug and Nasal Vaccine Makes Headway in Trials
2021-09-29
Purine Repressing Probiotic Might Halt COVID-19, says Korean Researchers
2020-03-21
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top